CAS NO: | 2040291-27-6 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | LLY-283 is a potent, selective and oral protein arginine methyltransferase 5 (PRMT5) inhibitor, with anIC50of 22 nM and aKdof 6 nM for PRMT5:MEP50 complex, and shows antitumor activity. | ||||||||||||||||
IC50& Target | IC50: 22 nM (PRMT5:MEP50)[1] | ||||||||||||||||
体外研究 (In Vitro) | LLY-283 is a potent, oral and selective arginine methyltransferase 5 (PRMT5) inhibitor, with an IC50of 22 nM in vitro and 25 nM in cells, as well as a Kdof 6 nM for PRMT5:MEP50 complex in vitro; LLY-283 inhibits the proliferation of A375 cell with an IC50of 46 nM[1]. | ||||||||||||||||
体内研究 (In Vivo) | LLY-283 (20 mg/kg; p.o., QD (once a day)) causes a significant inhibition on tumor growth in mice bearing A375 cells after treatment for 28 days[1]. | ||||||||||||||||
分子量 | 342.35 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C17H18N4O4 | ||||||||||||||||
CAS 号 | 2040291-27-6 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 125 mg/mL(365.12 mM;Need ultrasonic) H2O : 3.57 mg/mL(10.43 mM;ultrasonic and warming and heat to 60℃) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|